The Pulmonary Injury and Repair Center at the University of Alabama at Birmingham has produced a major return on investment in its six years of existence. The Center, begun in 2008 with an initial investment of $140,000 from the UAB School of Medicine, Department of Anesthesiology and Southern Research Institute, has since received nearly $10 million in research funding from government and industry sources.
Those funds have spurred scientific research, recruited new faculty and produced new knowledge in treating lung injury, especially from chemical agents such as chlorine, ammonia and bromine.
Chlorine, ammonia and bromine are commonly used in various industrial applications and are routinely shipped across the country. Exposure to these agents could come as a result of a deliberate terror attack or from an inadvertent leak from a transportation mishap.
“Inhalation of these gases can cause extreme, possibly fatal injury to the lungs,” said Sadis Matalon, Ph.D., distinguished professor and vice chair for research in the Department of Anesthesiology, and director of the center. “Our research is geared toward finding countermeasures that could be employed to minimize pulmonary injury in the event of a chlorine, ammonia or bromine release, whatever the cause may be.”
The UAB center is part of the federal government’s CounterACT Program. Funded by the National Institutes of Health, CounterACT is a translational research program aimed at the discovery and/or identification of better therapeutic medical countermeasures and technologies against chemical threat agents. CounterACT was launched following the terror attacks on Sept. 11, 2001, as awareness grew of potential threats from chemical agents.
UAB is one of the few research institutions in the nation involved in countermeasure research against chlorine and ammonia, and it is the only site looking for agents that would be effective against bromine, according to Matalon.
“We are investigating multiple strategies to respond to lung injury in the event of exposure to these agents,” Matalon said. “We have identified compounds that in preliminary studies have been shown to prevent death after chlorine exposure, for example. Compounds such as antioxidants and nitrites also have promise in reducing or reversing the toxic effects of these agents.”
Matalon says one of the center’s strengths is its reach across the breadth of UAB. Investigators involved in the major projects come from multiple disciplines and include Victor Darley-Usmar, Ph.D., and Jianhua Zhang, Ph.D., pathology; Tim Ness, M.D., anesthesiology; Chad Steele, Ph.D., and Veena Antony, M.D., pulmonary medicine; Rakesh Patel, Ph.D., molecular and cellular pathology; Mohammad Athar, dermatology; and Anupam Agarwal, M.D., nephrology. Other prominent investigators include Edward Postlethwait, Ph.D., Michelle Fanucchi, Ph.D., and Giuseppe Squadrito, Ph.D., in the School of Public Health; as well as James and Diana Noah, Ph.D.s, with Southern Research Institute.
Matalon and Darley-Usmar received a grant to test the role of mitochondrial injury in the initiation and propagation of chlorine injury to the lungs. Matalon is also collaborating with Sven Eric Jordt, Ph.D., of Yale University, to test the effectiveness of a new class of anti-inflammatory agents to decrease chlorine injury.
Patel was recently funded by the CounterACT Program to test the efficacy of nitrites to decrease mortality and lung injury in chlorine-exposed animals. Athar is funded by CounterACT to develop therapeutic interventions of lewisite-mediated injury to the skin, which could contribute to lung injury. Ness was also funded to investigate whether local anesthetics administered post-exposure reduce pain.
“This is a critical issue because people who experience pain have decreased ability to walk away from the epicenter of a chemical attack,” Matalon said.
The center also played a role in the recruitment of prominent new faculty to UAB, says Matalon, including Victor Thannickal, M.D., chair of the Division of Pulmonary, Allergy and Critical Care Medicine, and Jean-Francois Pittet, M.D., professor of anesthesiology.
“The Pulmonary Injury and Repair Center has enhanced collaborations among basic and clinical investigators at UAB and has driven translational research in lung injury and repair,” Matalon said. “It has also strengthened existing interactions among researchers from UAB and Southern Research Institute. These interactions continue to improve our ability to attract new faculty interested in pulmonary research at UAB and to compete for extramural awards.”
Williams earns grant to study perceptions of discrimination in health careJessica Williams, Ph.D., assistant professor in the UAB Department of Health Services Administration, received a $100,000 New Connections grant from the Robert Wood Johnson Foundation to examine perceptions of discrimination in health care settings.posted today 99 viewsSustainability experts considering ways to revitalize metro areaThe UAB Sustainable Smart Cities Research Center brought together green experts from around the world for the fourth annual Sustainable Smart Cities Symposium.posted today 128 viewsLow-carb diet could help adults with spinal cord injuryA new study from UAB could provide the first known data about the impact of dietary patterns on dietary adherence and cardiometabolic risk factors in adults with spinal cord injury.posted yesterday 251 viewsUAB student invited to present winning research at biomedical conferenceSagar Kaushik will present his research at a conference Oct. 9.posted yesterday 309 viewsUAB professor named a community Game ChangerProfessor Anthony Hood will receive special recognition for his work creating the NHabit Bush Hills project during the 2015 Vulcans Community Awards.posted yesterday 1169 viewsUAB study uses smartphone technology to promote pulmonary rehab at homeTelemedicine helps UAB take pulmonary rehabilitation into the home via smartphone technology, in an effort to reduce hospital readmissions from COPD.posted 2 days ago 701 viewsUAB study finds possible frontline therapy for older patients with Hodgkin LymphomaUAB researcher reports that brentuximab vedotin may be effective therapy for older patients with Hodgkin Lymphoma who cannot tolerate standard therapy.posted 3 days ago 602 viewsPlatform1 visual arts event at UAB’s 2300 Studios on Oct. 17 to benefit scholarshipsDiscover artists in their studios, participate in workshops and demonstrations, and purchase artwork to support UAB Department of Art and Art History student scholarships.posted 6 days ago 1003 viewsTugs and pulls: How a molecular motor untangles proteinE. coli ClpB is a bacterial enzyme that untangles proteins. Such tangles are hallmarks of neurodegenerative diseases like Parkinson’s and Alzheimer’s. A study led by UAB's Aaron Lucius, Ph.D., offers new insight on this amazing molecular machine, and could eventually point toward new treatment approaches.posted 8 days ago 1322 views
UAB Medicine-Leeds clinic to open Oct. 21The new internal medicine and pediatric clinic will feature an outpatient diagnostic center with a cutting-edge imaging facility and full ambulatory lab services, all on-site.posted 10 days ago 1985 viewsKing crabs threaten Antarctic ecosystem due to warming oceanPredators’ arrival could radically alter marine lifeposted 10 days ago 1973 viewsUAB research finds automated voice imitation can fool humans and machinesUAB researchers have found automated and human verification for voice-based user authentication vulnerable, and explore how an attacker in possession of voice audio samples could compromise a victim’s security, safety and privacy.posted 13 days ago 4305 viewsStandard treatment better than proposed alternative for unexplained infertilityClomiphene is more effective than letrozole for achieving pregnancy, NIH-funded study finds.posted 15 days ago 1105 viewsNew multidisciplinary clinical center for care, diagnosis and state-of-the-art researchThe Foundation for Mitochondrial Medicine, UAB and Seahorse Bioscience announce establishment of comprehensive mitochondrial patient care clinical program.posted 15 days ago 1537 viewsPossible contributor to the virulence of the 1918 flu pandemic discoveredUAB researchers discover a new protein interaction from the 1918 flu strain that may help influenza circumvent the host immune response that would fight viral infection.posted 16 days ago 2747 viewsUAB announces joint M.D./MBA degree offeringThe new M.D./MBA program is accepting applicants for the summer of 2016 for first-year medical students.posted 16 days ago 2353 views$1 billion Campaign for UAB surpasses $600 million markUAB’s Campaign for UAB has raised more than $617 million toward its $1 billion goal in the university’s largest-ever and most comprehensive philanthropic campaign.posted 16 days ago 2033 viewsStarting strong in scienceUAB freshman Priya Shah is already a veteran in the lab. In her senior year of high school, she began a tissue-engineering project with UAB researcher Joel Berry, Ph.D., that has led to national honors — and could eventually affect patients worldwide.posted 17 days ago 626 viewsBlood tests reveal early signs of cardiovascular disease risk in obese African-American teensBlood tests in obese African-American teenage girls reveal immune system changes which ‘prime the system’ to develop cardiovascular disease later in life.posted 20 days ago 1270 viewsUAB receives prestigious funding for aging research centerAn interdisciplinary effort among the College of Arts and Sciences and several schools across campus results in a $2.5 million grant.posted 20 days ago 2373 views